Giuseppe D. De Rosa
Via Domenico Montesano 49
Naples, 80131, Italy
Naples, 80131, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 105 publications
Nature Meets Science: The Role of Food-Grade Oils and Green Excipients in Pharmaceutical Nanoemulsion Formulation.
Journal: Materials (Basel, Switzerland)
Published: December 12, 2025
Special issue: Phospholipids as functional ingredients in pharmaceutical formulations: Current advances and perspectives.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: October 20, 2025
Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune System.
Journal: International journal of molecular sciences
Published: May 29, 2025
Lipid self-assembling nanoparticles as a novel platform for mRNA-based vaccination.
Journal: Molecular therapy. Nucleic acids
Published: May 07, 2025
Erratum: miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma.
Journal: Molecular therapy. Nucleic acids
Published: April 10, 2025
miRNA-503 inhibition exerts anticancer effects and reduces tumor growth in mesothelioma.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 17, 2024
Correction: Belisario et al. ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma. Cells 2020, 9, 647.
Journal: Cells
Published: December 12, 2024
Author Correction: Targeted inhibition of ubiquitin signaling reverses metabolic reprogramming and suppresses glioblastoma growth.
Journal: Communications biology
Published: October 30, 2024
Correction: TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 28, 2024
Nanoparticles encapsulating phosphatidylinositol derivatives promote neuroprotection and functional improvement in preclinical models of ALS via a long-lasting activation of TRPML1 lysosomal channel.
Journal: Pharmacological research
Published: July 12, 2024
Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study.
Journal: Cancers
Published: July 08, 2024
Last Updated: 09/26/2026